Ribosomes, often referred to as the cell's protein factories, translate messenger RNA (mRNA) into a specific sequence of ...

According to Dr Erik Wiklund, CEO of Circio, Norway, “mRNA vaccines are fast to manufacture and manufacturers can quickly and precisely alter the antigen sequence to generate new versions.

This important manuscript provides insights into the competition between Splicing Factor 1 (SF1) and Quaking (QKI) for binding at the ACUAA branch point sequence in a model intron, regulating exon ...

The article by Sarfaraz K. Niazi, PhD, argues that the FDA’s classification of future copies of messenger RNA (mRNA) products ...

Production tips from Crystal Bio, TriLink Biotechnologies, Ginkgo Bioworks, Quantoom Biosciences, and Parexel.

In 2021, with the COVID-19 pandemic in full swing, BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) were the darlings of the pharma and biotech worlds. The two mRNA therapy developers created ...

Large vaccine companies are reluctant to invest too heavily in the emerging technology due to a gap in knowledge, especially compared to mRNA therapeutics. Despite this, those familiar with ...

difficile or C. diff. In animal models, this first mRNA-LNP C. difficile vaccine was found to protect against C. difficile first-time infections and relapsing infections by inducing a robust ...

difficile or C. diff. In animal models, this first mRNA-LNP C. difficile vaccine was found to protect against C. difficile first-time infections and relapsing infections by inducing a robust ...

mRNA vaccines have gained widespread attention for their crucial role in fighting the COVID-19 pandemic. Yet, even before the ...

However, the speed of vaccine production is limited because the mRNA used in it is partly chemically synthesized and partly synthesized using enzymes, a relatively slow process. A team of ...

However, production of the mRNA used in vaccines is hindered by its production, which involves both chemical synthesis and a slower enzyme-mediated process. A team of researchers has successfully ...